113 related articles for article (PubMed ID: 19317327)
1. Using liver enzymes as screening tests to predict mortality risk.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2008; 40(3-4):191-203. PubMed ID: 19317327
[TBL] [Abstract][Full Text] [Related]
2. Mortality associated with bilirubin levels in insurance applicants.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2009; 41(1):49-53. PubMed ID: 19518005
[TBL] [Abstract][Full Text] [Related]
3. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
[TBL] [Abstract][Full Text] [Related]
4. Liver function tests and mortality in a cohort of life insurance applicants.
Pinkham CA; Krause KJ
J Insur Med; 2009; 41(3):170-7. PubMed ID: 20377096
[TBL] [Abstract][Full Text] [Related]
5. Association of Liver Function Tests with Mortality in an Insurance Applicant Population.
Rigatti SJ; Stout R
J Insur Med; 2022 Jul; 49(3):172-182. PubMed ID: 36378891
[TBL] [Abstract][Full Text] [Related]
6. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
[TBL] [Abstract][Full Text] [Related]
7. The population distributions, upper normal limits and correlations between liver tests among Australian adolescents.
George J; Denney-Wilson E; Okely AD; Hardy LL; Aitken R
J Paediatr Child Health; 2008 Oct; 44(10):579-85. PubMed ID: 19012630
[TBL] [Abstract][Full Text] [Related]
8. Trends in mortality of insurance applicants with HIV infection.
Stout RL; Fulks M; Dolan VF
J Insur Med; 2012; 43(2):67-75. PubMed ID: 22876410
[TBL] [Abstract][Full Text] [Related]
9. Alcohol abuse and liver enzymes (AALE): results of an intercompany study of mortality.
Titcomb C; Braun R; Roudebush B; Mast J; Woodman H;
J Insur Med; 2001; 33(3):277-89. PubMed ID: 11558411
[TBL] [Abstract][Full Text] [Related]
10. Serum globulin predicts all-cause mortality for life insurance applicants.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
[TBL] [Abstract][Full Text] [Related]
11. [Dependency on age of laboratory values in dogs and cats. 1. Enzyme activities in blood serum].
Kraft W; Hartmann K; Dereser R
Tierarztl Prax; 1995 Oct; 23(5):502-8. PubMed ID: 8585065
[TBL] [Abstract][Full Text] [Related]
12. Albumin and all-cause mortality risk in insurance applicants.
Fulks M; Stout RL; Dolan VF
J Insur Med; 2010; 42(1):11-7. PubMed ID: 21290995
[TBL] [Abstract][Full Text] [Related]
13. Metabolically healthy but obese individuals: relationship with hepatic enzymes.
Messier V; Karelis AD; Robillard ME; Bellefeuille P; Brochu M; Lavoie JM; Rabasa-Lhoret R
Metabolism; 2010 Jan; 59(1):20-4. PubMed ID: 19709695
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during phase 1 clinical trials.
Cantilena LR; Cherstniakova SA; Saviolakis G; Kahn R; Elkashef A; Rose L; Vocci F
Contemp Clin Trials; 2007 Nov; 28(6):695-704. PubMed ID: 17544338
[TBL] [Abstract][Full Text] [Related]
15. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
16. Comparative mortality in asymptomatic men issued standard insurance with routine ECG classified as normal or with minor T wave changes.
Singer RB
J Insur Med; 2008; 40(3-4):186-90. PubMed ID: 19317326
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
18. Laboratory and biometric predictors of cancer-related mortality in an insured population.
Palmier J; Lanzrath BJ
J Insur Med; 2012; 43(3):162-8. PubMed ID: 23451617
[TBL] [Abstract][Full Text] [Related]
19. Treadmill value in apparently healthy life insurance applicants.
Mihelic AH; Tak JA; Rullestad C
J Insur Med; 2002; 34(1):12-25. PubMed ID: 15303590
[TBL] [Abstract][Full Text] [Related]
20. Relationship of hemoglobin A1c to mortality in nonsmoking insurance applicants.
Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
J Insur Med; 2007; 39(3):174-81. PubMed ID: 18251376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
